|
Market Closed -
Other stock markets
|
Pre-market 17:38:43 | |||
| 758.91 USD | -1.18% |
|
750.25 | -1.14% |
| 01-14 | Regeneron's Yancopoulos on Hearing Loss Gene Therapy, Weight Loss Drugs | MT |
| 01-13 | Jefferies Adjusts Price Target on Regeneron Pharmaceuticals to $885 From $870, Maintains Buy Rating | MT |
EPS & Dividend: Regeneron Pharmaceuticals, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | 3.672 | 3.906 | 4.471 |
| Rate of return | - | - | - | - | - | 0.48% | 0.51% | 0.59% |
| EPS 2 | 30.52 | 71.97 | 38.22 | 34.77 | 38.34 | 40.84 | 39.56 | 48.03 |
| Distribution rate | - | - | - | - | - | 8.99% | 9.87% | 9.31% |
| Reference price 2 | 483.11 | 631.52 | 721.49 | 878.29 | 712.33 | 758.91 | 758.91 | 758.91 |
| Nbr of stocks (in thousands) | 105,544 | 104,556 | 106,802 | 106,347 | 107,590 | 102,599 | 102,599 | - |
| Announcement Date | 05/02/21 | 04/02/22 | 03/02/23 | 02/02/24 | 04/02/25 | - | - | - |
1USD in Million2USD
Estimates
Past dividends: Regeneron Pharmaceuticals, Inc.
| 20/11/2025 | Quarterly 0.88 USD |
| 18/08/2025 | Quarterly 0.88 USD |
| 20/05/2025 | Quarterly 0.88 USD |
| 20/02/2025 | Quarterly 0.88 USD |
Upcoming events: Regeneron Pharmaceuticals, Inc.
More events
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 0.48% | 0.51% | 18.58x | 2.44x | 5.02x | |
| -.--% | -.--% | 57.48x | 7.73x | 15.2x | |
| 2.67% | 2.9% | 22.12x | 2.76x | 4.04x | |
| 0.56% | 0.57% | 42.64x | 4.43x | 6.72x | |
| -.--% | -.--% | 17.18x | 1.42x | 2.84x | |
| -.--% | -.--% | 16.7x | 3.52x | 3.28x | |
| -.--% | 0.02% | 81.88x | 7.94x | 9.8x | |
| - | - | 351.99x | 63.63x | 106.79x | |
| -.--% | -.--% | -23.12x | -7.46x | 33.14x | |
| - | - | - | - | - | |
| Average | 0.46% | 0.5% | 65.05x | 9.60x | 20.76x | |
| Weighted average by Cap. | 0.66% | 0.71% | 47.81x | 6.62x | 13.17x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition